日本ケミファの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/05/11 | 1,803 | 1,819 | 1,803 | 1,819 | +4 | +0.2% | 300 |
2023/05/10 | 1,822 | 1,822 | 1,800 | 1,815 | -3 | -0.2% | 3,300 |
2023/05/09 | 1,807 | 1,828 | 1,802 | 1,818 | +9 | +0.5% | 2,800 |
2023/05/08 | 1,808 | 1,813 | 1,802 | 1,809 | +1 | +0.1% | 2,300 |
2023/05/02 | 1,800 | 1,810 | 1,791 | 1,808 | -4 | -0.2% | 1,900 |
2023/05/01 | 1,795 | 1,812 | 1,795 | 1,812 | +15 | +0.8% | 1,500 |
2023/04/28 | 1,785 | 1,797 | 1,780 | 1,797 | +9 | +0.5% | 1,300 |
2023/04/27 | 1,801 | 1,805 | 1,788 | 1,788 | -11 | -0.6% | 12,600 |
2023/04/26 | 1,805 | 1,811 | 1,795 | 1,799 | -3 | -0.2% | 3,600 |
2023/04/25 | 1,809 | 1,813 | 1,800 | 1,802 | +1 | +0.1% | 4,100 |
2023/04/24 | 1,810 | 1,810 | 1,801 | 1,801 | -2 | -0.1% | 1,300 |
2023/04/21 | 1,801 | 1,808 | 1,801 | 1,803 | +3 | +0.2% | 1,300 |
2023/04/20 | 1,801 | 1,813 | 1,800 | 1,800 | -1 | -0.1% | 3,600 |
2023/04/19 | 1,814 | 1,814 | 1,796 | 1,801 | -13 | -0.7% | 1,900 |
2023/04/18 | 1,790 | 1,817 | 1,790 | 1,814 | +33 | +1.9% | 5,300 |
2023/04/17 | 1,777 | 1,784 | 1,777 | 1,781 | -5 | -0.3% | 1,600 |
2023/04/14 | 1,801 | 1,808 | 1,778 | 1,786 | -15 | -0.8% | 3,600 |
2023/04/13 | 1,809 | 1,810 | 1,800 | 1,801 | -4 | -0.2% | 2,700 |
2023/04/12 | 1,805 | 1,805 | 1,805 | 1,805 | ±0 | ±0% | 400 |
2023/04/11 | 1,800 | 1,805 | 1,785 | 1,805 | +6 | +0.3% | 7,900 |
2023/04/10 | 1,785 | 1,800 | 1,785 | 1,799 | +17 | +1% | 1,100 |
2023/04/07 | 1,780 | 1,794 | 1,780 | 1,782 | +9 | +0.5% | 2,900 |
2023/04/06 | 1,817 | 1,817 | 1,773 | 1,773 | -28 | -1.6% | 3,100 |
2023/04/05 | 1,819 | 1,820 | 1,801 | 1,801 | -37 | -2% | 3,600 |
2023/04/04 | 1,835 | 1,846 | 1,835 | 1,838 | +9 | +0.5% | 5,700 |
2023/04/03 | 1,839 | 1,840 | 1,829 | 1,829 | -10 | -0.5% | 3,000 |
2023/03/31 | 1,841 | 1,847 | 1,816 | 1,839 | -6 | -0.3% | 3,300 |
2023/03/30 | 1,876 | 1,876 | 1,835 | 1,845 | +39 | +2.2% | 8,900 |
2023/03/29 | 1,790 | 1,806 | 1,790 | 1,806 | +4 | +0.2% | 3,200 |
2023/03/28 | 1,797 | 1,810 | 1,797 | 1,802 | -1 | -0.1% | 3,000 |
2023/03/27 | 1,795 | 1,807 | 1,791 | 1,803 | +27 | +1.5% | 3,800 |
2023/03/24 | 1,770 | 1,776 | 1,770 | 1,776 | +4 | +0.2% | 1,600 |
2023/03/23 | 1,764 | 1,780 | 1,763 | 1,772 | +8 | +0.5% | 2,500 |
2023/03/22 | 1,773 | 1,773 | 1,752 | 1,764 | +12 | +0.7% | 5,300 |
2023/03/20 | 1,757 | 1,775 | 1,744 | 1,752 | -45 | -2.5% | 5,800 |
2023/03/17 | 1,770 | 1,815 | 1,770 | 1,797 | +27 | +1.5% | 3,400 |
2023/03/16 | 1,765 | 1,775 | 1,764 | 1,770 | -12 | -0.7% | 2,200 |
2023/03/15 | 1,771 | 1,804 | 1,771 | 1,782 | +11 | +0.6% | 4,500 |
2023/03/14 | 1,784 | 1,784 | 1,768 | 1,771 | -26 | -1.4% | 3,500 |
2023/03/13 | 1,801 | 1,801 | 1,783 | 1,797 | -4 | -0.2% | 4,500 |
2023/03/10 | 1,793 | 1,807 | 1,792 | 1,801 | +2 | +0.1% | 8,500 |
2023/03/09 | 1,798 | 1,799 | 1,787 | 1,799 | +5 | +0.3% | 2,500 |
2023/03/08 | 1,791 | 1,794 | 1,783 | 1,794 | +3 | +0.2% | 3,000 |
2023/03/07 | 1,797 | 1,798 | 1,790 | 1,791 | -8 | -0.4% | 1,400 |
2023/03/06 | 1,799 | 1,803 | 1,790 | 1,799 | +6 | +0.3% | 5,400 |
2023/03/03 | 1,772 | 1,800 | 1,772 | 1,793 | +21 | +1.2% | 4,700 |
2023/03/02 | 1,766 | 1,783 | 1,766 | 1,772 | -15 | -0.8% | 3,300 |
2023/03/01 | 1,761 | 1,796 | 1,761 | 1,787 | +39 | +2.2% | 10,700 |
2023/02/28 | 1,755 | 1,755 | 1,746 | 1,748 | -13 | -0.7% | 2,400 |
2023/02/27 | 1,755 | 1,761 | 1,750 | 1,761 | +21 | +1.2% | 4,800 |
251~
300
件表示中 / 3457件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日ケミファ | 156,600円 | +2.5% | - | 3.19% | 94.17倍 | 0.31倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
VIS | 108,000円 | +87.8% | +265.7% | 0.00% | 64.86倍 | 4.45倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
カイオム | 12,400円 | +2.6% | - | 0.00% | - | 6.08倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
ノイルイミューン | 14,700円 | -5.1% | - | 0.00% | - | 1.12倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
サイフューズ | 73,200円 | +891.8% | - | 0.00% | - | 1.86倍 |
|
バイオ3Dプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
市場注目の銘柄
チャート関連のコラム